← Back to screener

Acadia Healthcare Company, Inc. ACHC

Rank #1072 · Nasdaq · $2.8B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
54.0
P/E
-127.5
P/B
0.98
ROE
-0.8%
Op. Margin
–%
Debt Ratio
98%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Average

P/E -127.5x, P/B 0.98x. Ranks in the top 42% of the universe.

Profitability ★★☆☆☆
Weak

ROE -0.8%. Ranks in the top 70% of the universe.

Safety ★★★☆☆
Good

Debt ratio 98%. Ranks in the top 39% of the universe.

Growth ★★★★☆
Good

Revenue growth of 12.2% year over year. Ranks in the top 30% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011––$0.0B$0.0B–81
2012––$0.0B$0.1B–329
2013––$-0.0B$0.1B–572
2014–$0.1B$0.0B$0.1B–772
2015–$0.1B$0.0B$0.4B–307
2016–$0.2B$0.1B$0.5B–538
2017–$0.4B$0.1B$0.9B–436
2018$2.8B$0.6B$0.0B$1.7B21.7228
2019$2.8B$0.6B$0.2B$2.2B21.3176
2020$1.9B–$-0.2B$2.6B–169
2021$2.0B–$0.1B$2.3B–195
2022$2.1B–$-0.7B$2.5B–87
2023$2.3B–$0.2B$1.9B–110
2024$2.6B–$0.3B$2.5B–98
2025$2.9B–$-0.0B$2.8B–98

← See the full screener